Review article · 2018
From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles
Journal of Medicinal Chemistry, 61(24), 10996–11020 · Published 19 July 2018 · DOI 10.1021/acs.jmedchem.8b00876
In brief
“From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles” is a 2018 review article by Michael D. Delost and 3 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 418 citations as of 15 November 2026, which puts it in the top 5% of works published in 2018 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 418
- Most cited in
- 2025 (69)
- Field-weighted impact
- 2.11
- References
- 90
- Authors
- 4
Abstract
Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of U.S. Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017 reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T. (2018). From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Journal of Medicinal Chemistry, 61(24), 10996–11020. https://doi.org/10.1021/acs.jmedchem.8b00876
MLA 9
Delost, Michael D., et al. “From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.” Journal of Medicinal Chemistry, vol. 61, no. 24, 2018, pp. 10996–11020. https://doi.org/10.1021/acs.jmedchem.8b00876.
Chicago
Delost, Michael D., David T. Smith, Benton J. Anderson, and Jón T. Njardarson. 2018. “From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.” Journal of Medicinal Chemistry 61 (24): 10996–11020. https://doi.org/10.1021/acs.jmedchem.8b00876.
Harvard
Delost, M. D. et al. (2018) ‘From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles’, Journal of Medicinal Chemistry, 61(24), pp. 10996–11020. doi:10.1021/acs.jmedchem.8b00876.
IEEE
M. D. Delost, D. T. Smith, B. J. Anderson, and J. T. Njardarson, “From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles,” Journal of Medicinal Chemistry, vol. 61, no. 24, pp. 10996–11020, 2018, doi: 10.1021/acs.jmedchem.8b00876.
BibTeX
@article{delost2018from,
title = {{From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles}},
author = {Delost, Michael D. and Smith, David T. and Anderson, Benton J. and Njardarson, Jón T.},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {61},
number = {24},
pages = {10996--11020},
doi = {10.1021/acs.jmedchem.8b00876},
url = {https://doi.org/10.1021/acs.jmedchem.8b00876}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 3 | |
| 2019 | 20 | |
| 2020 | 38 | |
| 2021 | 44 | |
| 2022 | 60 | |
| 2023 | 57 | |
| 2024 | 60 | |
| 2025 | 69 | |
| 2026 | 67 |
Its field-weighted citation impact is 2.11: it has been cited 2.11 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- oxygen heterocycles
- FDA-approved drugs
- pharmaceuticals
- epoxides
- pyranose
- furanose
- macrolactones
- morpholine
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T. (2018). From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Journal of Medicinal Chemistry, 61(24), 10996–11020. https://doi.org/10.1021/acs.jmedchem.8b00876
How many times has this paper been cited?
418 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Michael D. Delost, David T. Smith, Benton J. Anderson, Jón T. Njardarson.
What is the DOI of this paper?
10.1021/acs.jmedchem.8b00876. The permanent link is https://doi.org/10.1021/acs.jmedchem.8b00876.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.